Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-03AEON3Power of Attorney for AEON Biopharma, Inc. Officer
This filing details a Power of Attorney granted by John Bencich, Chief Financial Officer of AEON Biopharma, Inc., to Alexander B. Wilson and Jennifer Sy. The attorneys-in-fact are authorized to execute and file Section 13 and Section 16 reports (Schedules 13D/13G, Forms 3, 4, and 5) with the SEC and other authorities o...
Nano CapBiotechnology
2026-04-03ANAB3Power of Attorney for Susannah Gray
This filing contains a Power of Attorney document empowering Daniel Faga, Dave McKeon, and Eric Loumeau to act as attorneys-in-fact for Susannah Gray. This authorization pertains to the execution and filing of SEC forms, specifically Forms 3, 4, and 5, related to transactions in the securities of AnaptysBio, Inc. ("Com...
Mid CapBiotechnology
2026-04-03ARDX3Ardelyx Officer Power of Attorney and Stock Holdings Disclosure
This SEC Form 3 filing discloses the initial beneficial ownership of Ardelyx, Inc. securities by Rajani Dinavahi, the company's Chief Medical Officer. The filing includes a power of attorney document executed on March 16, 2026, granting authority to company executives to file various SEC forms on Dinavahi's behalf. Din...
Small CapBiotechnology